{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:29:13Z","timestamp":1780054153302,"version":"3.54.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Conventional modalities of external-beam radiation therapy (EBRT) are associated with high incidences of severe vision-threatening ocular and orbital toxicities when used to treat orbital malignancies. We investigate toxicities associated with high-dose volumetric modulated arc therapy (VMAT), a commonly used contemporary treatment modality for these tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective analysis of malignant orbital tumors managed with adjuvant high-dose VMAT preceded by globe-salvaging surgical therapy (GST) or exenteration. Dosimetric quantitation of target volumes and critical structures was performed. Incidence and severity of ocular, orbital, and adnexal toxicities were evaluated and assessed with regard to conventional EBRT toxicities for orbital malignancies described in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighty-four subjects (mean age = 65.9 \u00b1 9.7 years) were included (N = 48 and N = 36 in GST and exenteration subgroups, respectively). Mean dose was 64.8 \u00b1 2.1 Gy to the planning target volume. Dosing to critical structures typically did not surpass known tissue tolerance limits. Median follow up was 18.3 months. Visual acuity in the GST subgroup was not significantly different after VMAT (0.25 \u00b1 0.06) compared with baseline (0.23 \u00b1 0.02; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.302). Whereas severe toxicities reported by major systematic analyses in the literature with older EBRT modalities were relatively common\u2014for example, retinopathy (16\u201340%), optic neuropathy (16%), and corneal perforation (13%)\u2014toxicities with VMAT were typically mild and less common. The most common toxicities with VMAT were mild dry eye (81.3%; 39\/48), cataract (21.1%; 8\/38 phakic eyes), and periocular dermatitis (15.5%; 13\/84). Vision-threatening toxicities, including severe corneal pathologies, retinopathy, or optic neuropathy, were rare. There were no contralateral ocular or adnexal toxicities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>High-dose VMAT for orbital malignancies demonstrated low incidence and severity of eye-related toxicity, in contradistinction to adverse events reported from conventional forms of radiotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iop.0000000000002001","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T22:02:10Z","timestamp":1626818530000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Ocular, Orbital, and Adnexal Toxicity With High-dose Volumetric Modulated Arc Radiation Therapy for Orbital Malignancies"],"prefix":"10.1097","volume":"38","author":[{"given":"Giancarlo A.","family":"Garcia","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Charlson","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Pacific Eye Associates and California Pacific Medical Center, San Francisco, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton","family":"Kolseth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Oregon Health & Science University, Portland, Oregon, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namju","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Kossler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Byers Eye Institute at Stanford University, Palo Alto, California, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"R1-20250529","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2010.09.056","article-title":"Ocular risks from orbital and periorbital radiation therapy: a critical review.","volume":"79","author":"Jeganathan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bjo.54.4.237","article-title":"Ocular complications after therapeutic irradiation.","volume":"54","author":"Macfaul","year":"1970","journal-title":"Br J Ophthalmol"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.survophthal.2009.06.004","article-title":"Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects.","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R5-20250529","first-page":"837","article-title":"Response of the normal eye to high dose radiotherapy.","volume":"10","author":"Parsons","year":"1996","journal-title":"Oncology (Williston Park)"},{"key":"R6-20250529","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.21037\/apm.2019.12.02","article-title":"Palliative radiation therapy for patients with orbital and ocular metastases.","volume":"9","author":"Chik","year":"2020","journal-title":"Ann Palliat Med"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/107327480401100507","article-title":"Orbital rhabdomyosarcoma.","volume":"11","author":"Karcioglu","year":"2004","journal-title":"Cancer Control"},{"key":"R8-20250529","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice.","volume":"84","author":"Teoh","year":"2011","journal-title":"Br J Radiol"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.2147\/OTT.S113119","article-title":"Volumetric modulated arc therapy for treatment of solid tumors: current insights.","volume":"10","author":"Macchia","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation.","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/bjo.60.4.236","article-title":"Effects of fast neutrons on the eye.","volume":"60","author":"Roth","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"R13-20250529","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0360-3016(94)90348-4","article-title":"Severe dry-eye syndrome following external beam irradiation.","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20250529","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications.","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bjophthalmol-2017-311134","article-title":"Corneal complications after orbital radiotherapy for primary epithelial malignancies of the lacrimal gland.","volume":"102","author":"Gore","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R16-20250529","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0360-3016(93)90310-R","article-title":"Radiation dose to the lens and cataract formation.","volume":"25","author":"Henk","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250529","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ijrobp.2004.07.664","article-title":"Preventing radiation retinopathy with hyperfractionation.","volume":"61","author":"Monroe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20250529","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0360-3016(94)90347-6","article-title":"Radiation retinopathy after external-beam irradiation: analysis of time-dose factors.","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-20250529","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90346-8","article-title":"Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.","volume":"30","author":"Parsons","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20250529","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision.","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"R21-20250529","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma.","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-20250529","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0360-3016(99)00057-7","article-title":"Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.","volume":"44","author":"Takeda","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20250529","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0030-1255330","article-title":"Radiotherapy for head and neck cancer.","volume":"24","author":"Yeh","year":"2010","journal-title":"Semin Plast Surg"},{"key":"R24-20250529","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bjo.2005.072892","article-title":"Mortality following exenteration for malignant tumours of the orbit.","volume":"89","author":"Rahman","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R25-20250529","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/01676830.2016.1176210","article-title":"Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.","volume":"35","author":"Nagendran","year":"2016","journal-title":"Orbit"},{"key":"R26-20250529","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12885-019-5964-y","article-title":"Outcomes of orbital malignancies treated with eye-sparing surgery and adjuvant particle radiotherapy: a retrospective study.","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Cancer"},{"issue":"suppl S468","key":"R27-20250529","article-title":"Outcomes and patterns of recurrence of orbital carcinomas treated with IMRT","volume":"87","author":"Tao","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-20250529","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijrobp.2013.11.065","article-title":"Excellent outcomes and orbital preservation for advanced T4 sinonasal cancers using combined chemotherapy, intensity modulated radiation therapy, and surgery: definitive management of head-and-neck squamous cell carcinoma.","volume":"88","author":"Gamez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Ophthalmic Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000002001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:07:24Z","timestamp":1748538444000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0000000000002001","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}